Humacyte Stock (NASDAQ: HUMA) stock price, news, charts, stock research, profile.
Open | $6.800 |
Close | - |
Volume / Avg. | 3.425M / 1.508M |
Day Range | 6.180 - 6.960 |
52 Wk Range | 1.960 - 6.620 |
Market Cap | $809.774M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 89 |
Short Interest | 4.37% |
Days to Cover | 3.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Humacyte (NASDAQ: HUMA) through any online brokerage.
Other companies in Humacyte’s space includes: Cogent Biosciences (NASDAQ:COGT), Burning Rock Biotech (NASDAQ:BNR), Sage Therapeutics (NASDAQ:SAGE), CareDx (NASDAQ:CDNA) and Tango Therapeutics (NASDAQ:TNGX).
The latest price target for Humacyte (NASDAQ: HUMA) was reported by Benchmark on Monday, May 13, 2024. The analyst firm set a price target for 15.00 expecting HUMA to rise to within 12 months (a possible 120.91% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Humacyte (NASDAQ: HUMA) is $6.7901 last updated Today at May 15, 2024 at 3:10 PM EDT.
There are no upcoming dividends for Humacyte.
Humacyte’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Humacyte.
Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.